Subscribe for great stories in your community!
Vitae Pharmaceuticals Inc., a Fort Washington biotechnology company, closed its public stock offering. It generated $35 million in proceeds, writes John George of the Philadelphia…
Before we send you to this site, please subscribe to our daily newsletter.